Paper410053
Pharmacological characterization of tardive dyskinesia.
Casey DE and 1 other. Psychopharmacology (Berl), 1977. Cited by 132 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacological characterization of tardive dyskinesia. Papers, record 410053. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/410053
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dyskinesia, Drug-Induced | Major topic |
| Adult | |
| Benztropine | |
| Clinical Trials as Topic | |
| Deanol | |
| Dopamine | |
| Droperidol | |
| Humans | |
| Levodopa | |
| Male | |
| Middle Aged | |
| Parasympatholytics | |
| Physostigmine | |
| Placebos | |
| Time Factors |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,195,991 | Increase in rat brain acetylcholine induced by choline or deanol. | Life Sci | 1975 | https://conductscience.org/library/papers/1195991 | PubMed |
| 2 | 4,358,998 | Physostigmine in choreiform movement disorders. | Neurology | 1974 | https://conductscience.org/library/papers/4358998 | PubMed |
| 3 | 4,855,678 | Deanol in the treatment of levodopa-induced dyskinesias. | Neurology | 1974 | https://conductscience.org/library/papers/4855678 | PubMed |
| 4 | 4,418,481 | Effect of cholinergic and anticholinergic agents on tardive dyskinesia. | J Neurol Neurosurg Psychiatry | 1974 | https://conductscience.org/library/papers/4418481 | PubMed |
| 5 | 175,391 | Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. | Psychopharmacologia | 1976 | https://conductscience.org/library/papers/175391 | PubMed |
| 6 | 1,110,712 | Letter: Dimethylaminoethanol for tardive dyskinesia. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1110712 | PubMed |
| 7 | 4,865,731 | Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. | Am J Psychiatry | 1968 | https://conductscience.org/library/papers/4865731 | PubMed |
| 8 | 5,112,211 | Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia. | J Neurol Sci | 1971 | https://conductscience.org/library/papers/5112211 | PubMed |
| 9 | 4,692,153 | Parasympathetic suppression of manic symptoms by physostigmine. | Arch Gen Psychiatry | 1973 | https://conductscience.org/library/papers/4692153 | PubMed |
| 10 | 4,555,831 | Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine. | Arch Gen Psychiatry | 1972 | https://conductscience.org/library/papers/4555831 | PubMed |
| 11 | 3,854 | Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. | Science | 1976 | https://conductscience.org/library/papers/3854 | PubMed |
| 12 | 4,593,518 | Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. | Psychopharmacologia | 1974 | https://conductscience.org/library/papers/4593518 | PubMed |
| 13 | 4,577,946 | Persistent dyskinesia. | Br J Psychiatry | 1973 | https://conductscience.org/library/papers/4577946 | PubMed |
| 14 | 5,676,019 | Pharmacological evidence for a cholinergic mechanism in brain involved in a special stereotyped behaviour of reserpinized rats. | Br J Pharmacol | 1968 | https://conductscience.org/library/papers/5676019 | PubMed |
| 15 | 4,214,673 | Comparison of thiopropazate and trifluoperazine on oral dyskinesia - a double blind study. | Curr Ther Res Clin Exp | 1974 | https://conductscience.org/library/papers/4214673 | PubMed |
| 16 | 4,279,161 | 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. | Curr Ther Res Clin Exp | 1974 | https://conductscience.org/library/papers/4279161 | PubMed |
| 17 | 770,514 | An evaluation of papaverine in tardive dyskinesia. | J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/770514 | PubMed |
| 18 | 1,134,525 | Letter: Choline for tardive dyskinesia. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1134525 | PubMed |
| 19 | 5,536,051 | [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy]. | Arzneimittelforschung | 1970 | https://conductscience.org/library/papers/5536051 | PubMed |
| 20 | 1,147,074 | Deanol in the treatment of tardive dyskinesia. | Am J Psychiatry | 1975 | https://conductscience.org/library/papers/1147074 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29,553,158 | Cholinergic medication for antipsychotic-induced tardive dyskinesia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29553158 | PubMed |
| 29,409,162 | Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29409162 | PubMed |
| 29,341,071 | Anticholinergic medication for antipsychotic-induced tardive dyskinesia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29341071 | PubMed |
| 8,867,868 | Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8867868 | PubMed |
| 7,373,324 | Oxiperomide in tardive dyskinesia. | J Neurol Neurosurg Psychiatry | 1980 | https://conductscience.org/library/papers/7373324 | PubMed |
| 7,047,137 | Management of tardive dyskinesia: current update. | Drugs | 1982 | https://conductscience.org/library/papers/7047137 | PubMed |
| 6,782,605 | Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6782605 | PubMed |
| 6,775,341 | Dopamine, acetylcholine, and GABA effects in acute dystonia in primates. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6775341 | PubMed |
| 6,135,761 | A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals. | J Neurol Neurosurg Psychiatry | 1983 | https://conductscience.org/library/papers/6135761 | PubMed |
| 6,117,919 | Neuroleptic-induced acute dyskinesias in rhesus monkeys. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6117919 | PubMed |
| 2,906,088 | Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables. | J Neurol Neurosurg Psychiatry | 1988 | https://conductscience.org/library/papers/2906088 | PubMed |
| 2,895,937 | GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/2895937 | PubMed |
| 2,895,483 | Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/2895483 | PubMed |
| 2,871,578 | Acute dystonia induced by neuroleptic drugs. | Psychopharmacology (Berl) | 1986 | https://conductscience.org/library/papers/2871578 | PubMed |
| 2,594,903 | Oro-facial dyskinesia and the sub-commissural part of the globus pallidus in the cat: role of acetylcholine and its interaction with GABA. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2594903 | PubMed |
| 1,979,705 | Tardive dyskinesia. | West J Med | 1990 | https://conductscience.org/library/papers/1979705 | PubMed |
| 117,492 | Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/117492 | PubMed |
| 112,632 | Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/112632 | PubMed |
| 111,283 | Mood alterations during deanol therapy. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/111283 | PubMed |
| 111,273 | Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/111273 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/410053
GET https://conductscience.org/api/papers/v1/410053/references?page=2